Detalhe da pesquisa
1.
The Current and Emerging Role of Statins in the Treatment of PCOS: The Evidence to Date.
Medicina (Kaunas)
; 60(2)2024 Jan 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38399531
2.
Brown Adipose Tissue: A New Potential Target for Glucagon-like Peptide 1 Receptor Agonists in the Treatment of Obesity.
Int J Mol Sci
; 24(10)2023 May 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37239935
3.
Insulin Metabolism in Polycystic Ovary Syndrome: Secretion, Signaling, and Clearance.
Int J Mol Sci
; 24(4)2023 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36834549
4.
Clinical Applicability of Patient- and Clinician-Reported Outcome Tools in the Management of Patients With Acromegaly.
Endocr Pract
; 28(7): 678-683, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35421593
5.
Metformin and Insulin Resistance: A Review of the Underlying Mechanisms behind Changes in GLUT4-Mediated Glucose Transport.
Int J Mol Sci
; 23(3)2022 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-35163187
6.
The Relationship between COVID-19 and Hypothalamic-Pituitary-Adrenal Axis: A Large Spectrum from Glucocorticoid Insufficiency to Excess-The CAPISCO International Expert Panel.
Int J Mol Sci
; 23(13)2022 Jun 30.
Artigo
Inglês
| MEDLINE | ID: mdl-35806331
7.
Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly.
Medicina (Kaunas)
; 58(12)2022 Nov 23.
Artigo
Inglês
| MEDLINE | ID: mdl-36556914
8.
Prolactin in Polycystic Ovary Syndrome: Metabolic Effects and Therapeutic Prospects.
Life (Basel)
; 13(11)2023 Oct 26.
Artigo
Inglês
| MEDLINE | ID: mdl-38004264
9.
Case Report: Multiple prolactinomas in a young man with Kallmann syndrome and familial hypocalciuric hypercalcemia.
Front Endocrinol (Lausanne)
; 14: 1248231, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37964948
10.
Cardiometabolic Risk, Peripheral Arterial Disease and Cardiovascular Events in Polycystic Ovary Syndrome: Time to Implement Systematic Screening and Update the Management.
Curr Vasc Pharmacol
; 21(6): 424-432, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37779406
11.
Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives.
Biomedicines
; 10(8)2022 Aug 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36009535
12.
Assessment of Eating Disorders and Eating Behavior to Improve Treatment Outcomes in Women with Polycystic Ovary Syndrome.
Life (Basel)
; 12(11)2022 Nov 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36431041
13.
Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a cellular metabolic treatment legacy effect?
Endocrine
; 75(3): 804-813, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34761355
14.
Genetic Variability in Antioxidative and Inflammatory Pathways Modifies the Risk for PCOS and Influences Metabolic Profile of the Syndrome.
Metabolites
; 10(11)2020 Oct 29.
Artigo
Inglês
| MEDLINE | ID: mdl-33138337